The rules have been developed in accordance with the Federal Law of the Russian Federation №180-FZ dated 23.06.2016 «On Biomedical Cell Products».
This initiative sets out general requirements for pre-clinical studies, production and quality control of biomedical cell products for medical use.
The rules establish a quality assurance system for the production of biomedical cell products and requirements for donor biological materials and cell lines used as starting material.